Stocksigma LogoStocksigma Logo

Nectar Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 1.1 (-98.5% YoY | -97.5% QoQ) ■ EBITDA: -668 (Profit to Loss YoY | +75.5% QoQ) ■ EBITDA Margin (%): -60,694 (Profit to Loss YoY | -5452492 bps

Nectar Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Nectar Lifesciences Ltd · Financial Result · 14 Nov 2026, 5:28 pm

Nectar Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 1.1 (-98.5% YoY | -97.5% QoQ) ■ EBITDA: -668 (Profit to Loss YoY | +75.5% QoQ) ■ EBITDA Margin (%): -60,694 (Profit to Loss YoY | -5452492 bps QoQ) ■ PAT: 272 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 0.14 (Loss to Profit YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Nectar Lifesciences Ltd

All Nectar Lifesciences Ltd announcements